IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

March Altus Capital Management LP

Q4 2015 Holdings

Filed 2016-02-16 | 10 holdings | $1.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$1.1M29,80199.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$1.6K8,5990.2%
Incyte Corp(INCY)COM45337C102$1.6K14,7560.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$1.6K2,9160.1%
Dexcom Inc(DXCM)COM252131107$1.6K19,0460.1%
Aratana Therapeutics Inc(PETXEUR)COM03874P101$1.2K218,5150.1%
Athenahealth IncCOM04685W103$7894,9000.1%
Lilly ELI & Co(LLY)COM532457108$7508,8980.1%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$36414,9620.0%
Edwards Lifesciences Corp(EW)COM28176E108$30338,3220.0%